Contraceptive use, both oral and parenteral, is associated with increased arterial stiffness in young healthy women
- PMID: 40075003
- PMCID: PMC12143984
- DOI: 10.1007/s12020-025-04208-9
Contraceptive use, both oral and parenteral, is associated with increased arterial stiffness in young healthy women
Abstract
Purpose: Previous studies on the impact on arterial health of contraceptive use, or across the menstrual phases, have yielded differing results. Furthermore, there is little research on the differences based on the delivery method of the contraceptive, oral vs parenteral contraceptives. In this study, we examined arterial health using three different physiological measures of arterial function and structure in contraceptive users and non-users.
Methods: Young, healthy women, between 18.0-25.9 years of age were enrolled in the study (n = 577). Menstrual phase and contraceptive use and type were assessed by questionnaire. Arterial stiffness was measured using pulse-wave velocity (PWV) and augmentation index (AIx). Arterial thickness was measured using carotid-intima media thickness (cIMT). Blood samples were analysed for various biomarkers, which were used in multivariate regressions to adjust for the effects of contraceptive use on vascular status.
Results: Contraceptive users had a higher PWV than non-users. The menstrual phase did not impact PWV. In a smaller subgroup analysis, comparing the types of contraceptives, oral or parenteral, did not impact PWV. AIx and cIMT did not differ significantly between any studied groups. Systolic blood pressure, BMI, serum lipids, C-reactive protein, and sex hormone binding globulin concentrations were higher in the contraceptive using group, but in multivariable models, these biomarkers had only limited impact on the association between contraceptive use and PWV.
Conclusion: In a population of young, healthy women, contraceptive users displayed higher PWV values. The effect could not be explained by the effect of contraceptives on androgenicity, blood pressure or lipids.
Keywords: Contraceptive; Menstrual phase; Pulse-wave velocity; SHBG; Young female adults; cIMT.
© 2025. The Author(s).
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.
Figures
Similar articles
-
Effect of sex, menstrual cycle phase, and monophasic oral contraceptive pill use on local and central arterial stiffness in young adults.Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H357-H365. doi: 10.1152/ajpheart.00039.2018. Epub 2018 Apr 20. Am J Physiol Heart Circ Physiol. 2018. PMID: 29677465 Free PMC article.
-
The impact of age and 24-h blood pressure on arterial health in acute ischemic stroke patients: The Norwegian stroke in the young study.J Clin Hypertens (Greenwich). 2021 Oct;23(10):1922-1929. doi: 10.1111/jch.14361. Epub 2021 Sep 7. J Clin Hypertens (Greenwich). 2021. PMID: 34492149 Free PMC article.
-
IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults.BMC Cardiovasc Disord. 2021 Mar 11;21(1):131. doi: 10.1186/s12872-021-01914-w. BMC Cardiovasc Disord. 2021. PMID: 33706704 Free PMC article.
-
Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity.Eur Radiol. 2019 Mar;29(3):1507-1517. doi: 10.1007/s00330-018-5705-7. Epub 2018 Sep 5. Eur Radiol. 2019. PMID: 30187117
-
Arterial stiffness and blood pressure are similar in naturally menstruating and oral contraceptive pill-using women during the higher hormone phases.Exp Physiol. 2022 Apr;107(4):374-382. doi: 10.1113/EP090151. Epub 2022 Mar 8. Exp Physiol. 2022. PMID: 35199392
References
-
- D Rosenbaum, P Giral, J Chapman, et al., Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort. Atherosclerosis 231(2), 436–441 (2013). - PubMed
-
- N Tentolouris, G Christodoulakos, I Lambrinoudaki, et al., Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women. J. Endocrinol. Invest. 28(4), 305–311 (2005). - PubMed
-
- H.J Teede, Y.L Liang, D Kotsopoulos, et al., A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin. Endocrinol. 55(5), 673–682 (2001). - PubMed
-
- P Angerer, S Stork, W Kothny, et al., Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler. Thromb. Vasc. Biol. 21(2), 262–268 (2001). - PubMed
-
- H.N. Hodis, W.J. Mack, Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis. J. Steroid Biochem. Mol. Biol. 142, 68–75 (2014) - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous